Rickey R. Reinhardt
Rickey R. Reinhardt publishes mostly in Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology, on topics such as Diabetes Treatment and Management, Diabetes Management and Research and Virus-based gene therapy research.
- World rank
- #1,303,582 of 7,710,434 ranked researchers
- Rank in United States
- #414,492 of 1,627,098
- Works
- 23
- Citations
- 1.7k
- Citations per work
- 74.7
What does Rickey R. Reinhardt research?
Rickey R. Reinhardt's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (17%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1356.1%
- Medicine1356.1%
- Everything else627.2%
- Life Sciences416.7%
- 1Endocrinology, Diabetes and Metabolism38% of their works
- 2Molecular Biology11% of their works
- 3Physiology8% of their works
- 4Genetics6% of their works
- 5Pulmonary and Respiratory Medicine6% of their works
- 6Oncology4% of their works
Research topics
- Diabetes Treatment and Management
- Diabetes Management and Research
- Virus-based gene therapy research
- Metabolism, Diabetes, and Cancer
- Growth Hormone and Insulin-like Growth Factors
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- CAR-T cell therapy research
Which keywords describe Rickey R. Reinhardt's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Cardiovascular Outcomes, Type 2 Diabetes, Cardiovascular Disease, Diabetes, Continuous Glucose Monitoring and Hypoglycemia.
- Metformin
- Insulin-like Growth Factors
- IGF-1
- Critical Care
- CAR T Cells
- Viral Vectors
- Hypoglycemia
- Diabetes
- Type 2 Diabetes
- Insulin Therapy
- Glycemic Control
- Cardiovascular Outcomes
- Cardiovascular Disease
- Continuous Glucose Monitoring
- Gene Therapy
- AMP-Activated Protein Kinase
- Chimeric Antigen Receptor
- Hyperglycemia
- Insulin Resistance
- Metabolic Syndrome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Glycemic Control183 topics
- Insulin Therapy183 topics
- Cardiovascular Outcomes101 topic
- Type 2 Diabetes101 topic
- Cardiovascular Disease82 topics
- Diabetes82 topics
- Continuous Glucose Monitoring51 topic
- Hypoglycemia51 topic
- Gene Therapy41 topic
- Viral Vectors41 topic
- AMP-Activated Protein Kinase31 topic
- CAR T Cells31 topic
- Chimeric Antigen Receptor31 topic
- Critical Care31 topic
- Hyperglycemia31 topic
- IGF-131 topic
- Insulin Resistance31 topic
- Insulin-like Growth Factors31 topic
- Metabolic Syndrome31 topic
- Metformin31 topic
Where does Rickey R. Reinhardt work?
Rickey R. Reinhardt's main affiliation in the publication record is Novo Nordisk (United States), United States.
How many publications and citations does Rickey R. Reinhardt have?
OpenAlex counts 23 works and 1,719 citations for Rickey R. Reinhardt, an h-index of 16, ranking #1,303,582 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rickey R. Reinhardt. Posts are plain text and can be reported.